Business Description
Genomtec SA
ISIN : PLGNMTC00017
Description
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.1 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.24 | |||||
| Debt-to-EBITDA | -0.26 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 7.3 | |||||
| Beneish M-Score | 4731.85 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 21.3 | |||||
| 3-Year EPS without NRI Growth Rate | 17.7 | |||||
| 3-Year FCF Growth Rate | -43 | |||||
| 3-Year Book Growth Rate | -10 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.07 | |||||
| 9-Day RSI | 51.41 | |||||
| 14-Day RSI | 52.74 | |||||
| 6-1 Month Momentum % | 22.37 | |||||
| 12-1 Month Momentum % | 38.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.11 | |||||
| Quick Ratio | 2.11 | |||||
| Cash Ratio | 1.33 | |||||
| Days Inventory | 42.22 | |||||
| Days Sales Outstanding | 462017 | |||||
| Days Payable | 541.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.5 | |||||
| Shareholder Yield % | -7.99 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -81000 | |||||
| Operating Margin % | -895700 | |||||
| Net Margin % | -901300 | |||||
| ROE % | -113.45 | |||||
| ROA % | -56.64 | |||||
| ROIC % | -88.58 | |||||
| ROC (Joel Greenblatt) % | -419.79 | |||||
| ROCE % | -66.14 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12900 | |||||
| PB Ratio | 19.05 | |||||
| Price-to-Tangible-Book | 300 | |||||
| EV-to-EBIT | -17.67 | |||||
| EV-to-EBITDA | -20.35 | |||||
| EV-to-Revenue | 155988.9 | |||||
| EV-to-FCF | -13.59 | |||||
| Earnings Yield (Greenblatt) % | -5.66 | |||||
| FCF Yield % | -7.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genomtec SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -0.174 | ||
| Beta | 0.33 | ||
| Volatility % | 25.46 | ||
| 14-Day RSI | 52.74 | ||
| 14-Day ATR (€) | 0.122643 | ||
| 20-Day SMA (€) | 2.64975 | ||
| 12-1 Month Momentum % | 38.14 | ||
| 52-Week Range (€) | 1.685 - 3.35 | ||
| Shares Outstanding (Mil) | 12.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genomtec SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genomtec SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genomtec SA Frequently Asked Questions
What is Genomtec SA(FRA:4VI)'s stock price today?
The current price of FRA:4VI is €2.67. The 52 week high of FRA:4VI is €3.35 and 52 week low is €1.69.
When is next earnings date of Genomtec SA(FRA:4VI)?
The next earnings date of Genomtec SA(FRA:4VI) is .
Does Genomtec SA(FRA:4VI) pay dividends? If so, how much?
Genomtec SA(FRA:4VI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers